Publications (7)12.87 Total impact
-
Article: Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature.
[show abstract] [hide abstract]
ABSTRACT: Headaches and nausea are the 2 most common adverse effects of electroconvulsive therapy (ECT). These adverse effects have been frequently reported in the postictal period and make it difficult for the patient to continue with the following ECTs. Mirtazapine is an antidepressant with a mechanism that involves activating serotonin (5-HT1) receptors. This mechanism has been hypothesized to be the underlying therapeutic effects for depression and anxiety. In addition, mirtazapine possesses antagonistic effects on the postsynaptic serotonin 5-HT2 and 5-HT3 receptors. The pharmacological actions are hypothesized to be related to its treatment effects of headaches and nausea. Here, we report a case series of patients developing post-ECT headaches and nausea, and the concomitant administration of mirtazapine successfully relieved the ECT-associated adverse effects. This case series suggest that mirtazapine may be an optional treatment for ECT-induced headaches and nausea.The journal of ECT 06/2011; 27(2):165-7. · 1.19 Impact Factor -
Article: Bradycardia following a single low dose of trazodone.
[show abstract] [hide abstract]
ABSTRACT: Symptomatic bradycardia following a single low dose of oral trazodone is rare. Herein, we report the case of a patient with major depressive disorder who developed and was able to resolve symptomatic bradycardia following administration of a single low dose of trazodone 50mg, and then discontinuation. This is the first case report of symptomatic bradycardia which might be attributed to a single lowest dose of trazodone in the world.Asian journal of psychiatry. 03/2011; 4(1):77-9. -
Article: Rapid weight gain during mirtazapine treatment.
The Journal of neuropsychiatry and clinical neurosciences 01/2011; 23(1):E7. · 2.34 Impact Factor -
Article: Amisulpride augmentation of clozapine in refractory schizophrenia.
The Journal of neuropsychiatry and clinical neurosciences 01/2011; 23(3):E15. · 2.34 Impact Factor -
Article: Trazodone ameliorates nightmares in major depressive disorder.
The Journal of neuropsychiatry and clinical neurosciences 01/2011; 23(1):E4. · 2.34 Impact Factor -
Article: Rapid control of manic symptoms during combination of electroconvulsive therapy and lithium.
The Journal of neuropsychiatry and clinical neurosciences 01/2011; 23(1):E18. · 2.34 Impact Factor -
Article: Pisa syndrome during amisulpride treatment.
The Journal of neuropsychiatry and clinical neurosciences 01/2010; 22(3):352s.e27-352.e27. · 2.34 Impact Factor
Top co-authors
Top Journals
Institutions
-
2011
-
Kaohsiung Armed Forces General Hospital
Kaohsiung, Kaohsiung, Taiwan
-
